Skip to main content
Premium Trial:

Request an Annual Quote

Nacalai to Distribute Techulon Transfection Reagents

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nacalai USA today said that it has signed an agreement to distribute Techulon's Glycofect Transfection Reagent platform products in Japan.

The reagents are designed to be particularly effective in primary cells of therapeutic interest, said Nacalai. In addition, the San Diego-based firm said that the Glycofect family of reagents has a unique biodegradable composition that provides for efficacious delivery with very low toxicity in key cell types.

Financial and other terms of the agreement were not disclosed.

Nacalai USA is a subsidiary of Nacalai Tesque, a Kyoto, Japan-based manufacturer and distributor of research products.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.